| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2004 | CN1511527A Use of tetrandrine in inhibiting vascularization medicine |
| 07/14/2004 | CN1511526A Rifaximin ointment |
| 07/14/2004 | CN1511525A Application of (+) North America coptisine |
| 07/14/2004 | CN1511524A Indapamide slow-releasing capsule and its preparing process |
| 07/14/2004 | CN1511523A New use of bergenin in treating chronic prostatitis and proliferative diseases |
| 07/14/2004 | CN1511522A Use of green chiretta diterpene lactone in inhibiting vascularization |
| 07/14/2004 | CN1511521A Use of goldenlarch bark acetic acid inhibiting vascularization |
| 07/14/2004 | CN1511520A Use of succinate derivative for biologically treating dementia |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1511518A Use of chrysophanic acid in inhibiting vascularization |
| 07/14/2004 | CN1511517A Magnolol and/or use of magnolol and its derivative in inhibiting vascularization |
| 07/14/2004 | CN1511514A Acetaminophen granule with slow releasing action and its preparing method |
| 07/14/2004 | CN1511458A Aspirin milk powder granule and its preparing process |
| 07/14/2004 | CN1157415C Alginate having low molecular weight, method for manufacturing it and its use |
| 07/14/2004 | CN1157404C Novel fusidic acid derivatives |
| 07/14/2004 | CN1157402C Organic compounds |
| 07/14/2004 | CN1157401C Neotoralactone, its derivatives and their application in reducing fat and lossing weight |
| 07/14/2004 | CN1157394C Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/14/2004 | CN1157393C Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine and its prep. |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157391C Method and intermediate for preparing is-a-oxazole formylamine and its analogue |
| 07/14/2004 | CN1157390C Indole derivant |
| 07/14/2004 | CN1157389C Quinolinecarboxylic acid derivative or salts thereof |
| 07/14/2004 | CN1157387C Process for preparing 11-amino-3-chlorine-6, 11-dihydrogen-5, 5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine |
| 07/14/2004 | CN1157386C Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections |
| 07/14/2004 | CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds |
| 07/14/2004 | CN1157381C Dicyclanil polymorphs and hydrates and their preparation |
| 07/14/2004 | CN1157380C Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157376C Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 07/14/2004 | CN1157375C Indole Ferivatives and medicinal compositions containing same |
| 07/14/2004 | CN1157372C Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/14/2004 | CN1157371C Monohydrate of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexancecarboxylate |
| 07/14/2004 | CN1157368C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 07/14/2004 | CN1157366C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/14/2004 | CN1157227C Use of low molecular weight amino alcohols in ophthalmic compositions |
| 07/14/2004 | CN1157225C Lectin compositions and uses tehreof |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157223C Dolastatin-15 derivatives in combination with taxanes |
| 07/14/2004 | CN1157217C Spraying medicine for treating tinea pedis and process for making same |
| 07/14/2004 | CN1157214C Pure Chinese medicine prepn for treating psychosis |
| 07/14/2004 | CN1157205C Ointment for treating ostalgia |
| 07/14/2004 | CN1157203C Chinese medicine external use lotion for treating skin diseases and its preparing method |
| 07/14/2004 | CN1157201C Composite non-opium medicine for dropping drugs |
| 07/14/2004 | CN1157199C Chinese medicine for treating hyperosteogeny, arthritis and herniation of cervical disc and prolapse of lumbar intervartebral disc and administration device thereof |
| 07/14/2004 | CN1157195C Soft capsule of superfine compound pearl powder and its preparing process |
| 07/14/2004 | CN1157193C Lotion for treating anal fistula and gynopathy |
| 07/14/2004 | CN1157192C Pharmaceutical application of crust holoside and derivant thereof |
| 07/14/2004 | CN1157191C Hyaluronic acid gel, process for preparation thereof and medical materials containing the same |
| 07/14/2004 | CN1157190C Application of sodium deoxy taurocholate as synergist for antituber culosis antibiotic |
| 07/14/2004 | CN1157189C Semi-synthetic ecteinascidins |
| 07/14/2004 | CN1157188C Method for inhibiting stress-activated protein kinases |
| 07/14/2004 | CN1157187C Remedies for renal failure |
| 07/14/2004 | CN1157186C Cholinergic agents in the treatment of presbyopia |
| 07/14/2004 | CN1157185C Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 07/14/2004 | CN1157181C Use of conjugated linoleic acid (CLA) for topical treatment of cellulite |
| 07/14/2004 | CN1157178C Composition for enhancing skin or hair |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762326 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 07/13/2004 | US6762320 Monoamine oxidase b inhibitors; alzheimer's disease, senile dementia |
| 07/13/2004 | US6762318 Glucagon antagonists |
| 07/13/2004 | US6762308 Method for the preparation of citalopram |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762205 Phenyl sulfamate derivatives |
| 07/13/2004 | US6762204 Taxol enhancer compounds |
| 07/13/2004 | US6762203 Mixture of glycerides, triglycerides and fatty acid; foods, drugs |
| 07/13/2004 | US6762202 Noninvasive method for measuring vasodilation or change in blood flow following administration of a compound that donates, transfers or releases nitric oxide |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762199 Ability to modulate the interaction of the ligand vcam-1 with its integrin receptor alpha 4 beta 1; treatment of inflammation, atherosclerosis, autoimmune disease |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762193 Method of treating hair loss |
| 07/13/2004 | US6762192 Useful in therapy and prophylaxis of epilepsy, migraine, and other disorders |
| 07/13/2004 | US6762191 Therapeutic compounds |
| 07/13/2004 | US6762190 Vitronectin receptor antagonists; suppressing osteoclast bone resorption; preventing angiogenesis or vascular smooth muscle proliferation |
| 07/13/2004 | US6762189 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762185 Pyrazino(1,2-a)pyrimidine derivatives; wnt-signaling pathway modulation |
| 07/13/2004 | US6762184 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 07/13/2004 | US6762182 Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| 07/13/2004 | US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762174 Beta-alethine with melphalan or cyclophosphamide; prevents clinical appearance of a neoplastic or pre-neoplastic condition; immunomodulation; enhancing cell growth, vitality, differentiation; antisenescence |
| 07/13/2004 | US6762171 Peroxisome proliferator-activated receptor antagonist for carbohydrate and lipid metabolism related diseases; diabetic ketoacidosis, obesity |
| 07/13/2004 | US6762170 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 07/13/2004 | US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy |
| 07/13/2004 | US6762158 Personal care compositions comprising liquid ester mixtures |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6761913 Controlled ethanolic extraction, distillation and drying, and further processing by supercritical fluid extractions, and may be further fractionated by column fractionation, distillation, lialh reduction, etc. |
| 07/13/2004 | US6761910 Sublingually administering a drug with a bioadhesion or mucoadhesion promoting compound; water soluble carrier particles; effective plasma levels within a short time; fentanyl analgesic |
| 07/13/2004 | US6761907 Coated dosage units |
| 07/13/2004 | US6761904 Pharmaceutical kit comprising midodrine as active drug substance |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761900 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |